Research Articles | Aplastic Anemia and MDS International Foundation

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Titlesort descending Original Publication Date Journal Bone Marrow Disease
Anti-Complement Treatment in Paroxysmal Nocturnal Hemoglobinuria: Where we Stand and Where we are Going Feb 2014 Transl Med UniSa paroxysmal nocturnal hemoglobinuria (PNH)
Aplastic anemia during pregnancy: a review of obstetric and anesthetic considerations Feb 2018 Int J Womens Health aplastic anemia
ASCO Updates Platelet Transfusion Guideline Prophylaxis unnecessary for adults undergoing HSCT Dec 2017 Medpage Today
Clinical activity and safety of the dual pathway inhibitor rigosertib for higher risk myelodysplastic syndromes following DNA methyltransferase inhibitor therapy Apr 2014 Hematol Oncol myelodysplastic syndromes (MDS)
Effectiveness and safety of different azacitidine dosage regimens in patients with myelodysplastic syndromes or acute myeloid leukemia Mar 2014 Leuk Res myelodysplastic syndromes (MDS)
Outcome of patients treated for myelodysplastic syndromes without deletion 5q after failure of lenalidomide therapy Feb 2017 Oncotarget myelodysplastic syndromes (MDS)
Outcomes in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with isolated deletion 5q treated with lenalidomide: a subset analysis from the MDS-004 study May 2014 Eur J Haematol myelodysplastic syndromes (MDS)
"Moderate" dose cyclophosphamide for severe aplastic anemia has significant toxicity and does not prevent relapse and clonal evolution Sep 2014 Blood aplastic anemia
"Moderate" dose cyclophosphamide for severe aplastic anemia has significant toxicity and does not prevent relapse and clonal evolution. Sep 2014 Blood aplastic anemia
(Auto-)immune signature in aplastic anemia. May 2018 Haematologica acute myeloid leukemia (AML)